Gateway Investment Advisers LLC decreased its stake in Zoetis Inc (NYSE:ZTS) by 7.2% during the 1st quarter, HoldingsChannel.com reports. The firm owned 19,167 shares of the company’s stock after selling 1,498 shares during the quarter. Gateway Investment Advisers LLC’s holdings in Zoetis were worth $1,930,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors also recently made changes to their positions in the company. Berman Capital Advisors LLC acquired a new position in Zoetis during the fourth quarter worth about $26,000. Athena Capital Advisors LLC acquired a new position in Zoetis during the fourth quarter worth about $29,000. Resources Investment Advisors Inc. acquired a new position in Zoetis during the fourth quarter worth about $31,000. Lavaca Capital LLC acquired a new position in Zoetis during the fourth quarter worth about $32,000. Finally, Acima Private Wealth LLC acquired a new position in Zoetis during the fourth quarter worth about $34,000. Institutional investors and hedge funds own 90.93% of the company’s stock.
Shares of ZTS stock opened at $101.67 on Monday. The company has a current ratio of 3.60, a quick ratio of 2.46 and a debt-to-equity ratio of 2.95. Zoetis Inc has a 12 month low of $77.00 and a 12 month high of $103.33. The stock has a market cap of $48.43 billion, a price-to-earnings ratio of 32.48, a PEG ratio of 1.83 and a beta of 0.93.
The business also recently declared a quarterly dividend, which will be paid on Monday, June 3rd. Stockholders of record on Thursday, April 18th will be paid a $0.164 dividend. This represents a $0.66 dividend on an annualized basis and a dividend yield of 0.65%. The ex-dividend date of this dividend is Wednesday, April 17th. Zoetis’s dividend payout ratio (DPR) is 21.09%.
A number of research firms recently weighed in on ZTS. Credit Suisse Group boosted their price target on shares of Zoetis from $102.00 to $112.00 and gave the stock an “outperform” rating in a research report on Tuesday, April 2nd. UBS Group initiated coverage on shares of Zoetis in a research note on Wednesday, March 20th. They set a “neutral” rating on the stock. SunTrust Banks initiated coverage on shares of Zoetis in a research note on Tuesday, March 19th. They set a “hold” rating and a $100.00 target price on the stock. Stifel Nicolaus raised shares of Zoetis from a “hold” rating to a “buy” rating and lifted their target price for the stock from $97.00 to $110.00 in a research note on Monday, March 4th. Finally, Zacks Investment Research raised shares of Zoetis from a “sell” rating to a “hold” rating in a research note on Saturday, February 16th. Six equities research analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. The company presently has a consensus rating of “Buy” and a consensus price target of $100.57.
In related news, insider Roman Trawicki sold 17,873 shares of Zoetis stock in a transaction that occurred on Friday, March 1st. The shares were sold at an average price of $95.10, for a total value of $1,699,722.30. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Roxanne Lagano sold 2,000 shares of Zoetis stock in a transaction that occurred on Monday, April 1st. The shares were sold at an average price of $101.89, for a total transaction of $203,780.00. Following the completion of the transaction, the insider now owns 30,727 shares of the company’s stock, valued at approximately $3,130,774.03. The disclosure for this sale can be found here. Insiders sold a total of 404,209 shares of company stock worth $38,052,349 over the last three months. Insiders own 0.35% of the company’s stock.
COPYRIGHT VIOLATION NOTICE: “Zoetis Inc (ZTS) Shares Sold by Gateway Investment Advisers LLC” was first reported by Week Herald and is the property of of Week Herald. If you are accessing this piece of content on another domain, it was stolen and republished in violation of international copyright & trademark legislation. The original version of this piece of content can be accessed at https://weekherald.com/2019/04/15/zoetis-inc-zts-shares-sold-by-gateway-investment-advisers-llc.html.
Zoetis Inc discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses.
Featured Story: Understanding debt-to-equity ratio in fundamental analysis
Want to see what other hedge funds are holding ZTS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zoetis Inc (NYSE:ZTS).
Receive News & Ratings for Zoetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis and related companies with MarketBeat.com's FREE daily email newsletter.